Literature DB >> 29649368

Mouse Models for Studying Oral Cancer: Impact in the Era of Cancer Immunotherapy.

J J Luo1,2, C D Young2, H M Zhou1, X J Wang2.   

Abstract

Model systems for oral cancer research have progressed from tumor epithelial cell cultures to in vivo systems that mimic oral cancer genetics, pathological characteristics, and tumor-stroma interactions of oral cancer patients. In the era of cancer immunotherapy, it is imperative to use model systems to test oral cancer prevention and therapeutic interventions in the presence of an immune system and to discover mechanisms of stromal contributions to oral cancer carcinogenesis. Here, we review in vivo mouse model systems commonly used for studying oral cancer and discuss the impact these models are having in advancing basic mechanisms, chemoprevention, and therapeutic intervention of oral cancer while highlighting recent discoveries concerning the role of immune cells in oral cancer. Improvements to in vivo model systems that highly recapitulate human oral cancer hold the key to identifying features of oral cancer initiation, progression, and invasion as well as molecular and cellular targets for prevention, therapeutic response, and immunotherapy development.

Entities:  

Keywords:  cancer biology; genetically engineered mouse models; immunity; immunocompetent; oral carcinogenesis; squamous cell carcinoma

Mesh:

Year:  2018        PMID: 29649368      PMCID: PMC6728551          DOI: 10.1177/0022034518767635

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  7 in total

1.  Identification of a novel immune gene panel in tongue squamous cell carcinoma.

Authors:  Jiwei Sun; Fengyuan Guo; Qingming Tang; Guangjin Chen; Jinfeng Peng; Yufeng Shen; Junyuan Zhang; Jingqiong Hu; Cheng Yang
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

2.  A signature of immune-related gene pairs (IRGPs) for risk stratification and prognosis of oral cancer patients.

Authors:  Yanling Yu; Jing Tian; Yanni Hou; Xinxin Zhang; Linhua Li; Peifu Cong; Lei Ji; Xuri Wang
Journal:  World J Surg Oncol       Date:  2022-07-08       Impact factor: 3.253

3.  Chemopreventive efficacy of salvianolic acid B phospholipid complex loaded nanoparticles against experimental oral carcinogenesis: implication of sustained drug release.

Authors:  Wei Liu; Zengtong Zhou; Laikuan Zhu; Hongquan Li; Lan Wu
Journal:  Ann Transl Med       Date:  2022-03

Review 4.  Mouse Models for Immune Checkpoint Blockade Therapeutic Research in Oral Cancer.

Authors:  Wei-Chiao Chiu; Da-Liang Ou; Ching-Ting Tan
Journal:  Int J Mol Sci       Date:  2022-08-16       Impact factor: 6.208

5.  RGS12 Represses Oral Cancer via the Phosphorylation and SUMOylation of PTEN.

Authors:  C Fu; G Yuan; S T Yang; D Zhang; S Yang
Journal:  J Dent Res       Date:  2020-11-16       Impact factor: 6.116

Review 6.  Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer.

Authors:  Fanglong Wu; Jin Yang; Junjiang Liu; Ye Wang; Jingtian Mu; Qingxiang Zeng; Shuzhi Deng; Hongmei Zhou
Journal:  Signal Transduct Target Ther       Date:  2021-06-10

7.  DMBA-Induced Oral Carcinoma in Syrian Hamster: Increased Carcinogenic Effect by Dexamethasone Coexposition.

Authors:  Diana A Martínez B; Paola Andrea Barato Gómez; Carlos Arturo Iregui Castro; Jaiver E Rosas Pérez
Journal:  Biomed Res Int       Date:  2020-02-13       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.